HemoCue

Quest Diagnostics HemoCue Subsidiary to Add U.S. Hospital Laboratory Connectivity to Its HemoCue 201 DM Point-of-Care Systems

Agreement with Medical Automation Systems, Inc. Will Add RALS(R)-Plus Module to Company's Hemoglobin and Glucose Handheld Devices MADISON, N.J., June 22 /PRNewswire-FirstCall/ -- HemoCue Inc., the U.S. point-of-care testing distribution subsidiary of Quest Diagnostics Incorporated (NYSE: ...

Quest Diagnostics HemoCue AB Subsidiary to Add Avie(TM) Hemoglobin A1c to Diabetes Point-of-Care Test Suite

Agreement to Distribute MEC HbA1c Test To Provide Physicians in U.S. and Europe With Fast, Accurate Near-Patient Test for Diabetes Monitoring MADISON, N.J., June 2 /PRNewswire-FirstCall/ -- HemoCue AB, an international company in the field of point-of-care testing and a subsidiary of Quest...

HemoCue in Medical Technology

Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance

...information and services, today announced that its hemocue and Focus Diagnostics subsidiaries have received F...t a year. "The HerpeSelect Express HSV-2 test and hemocue WBC Analyzer are important technologies that under...iate treatment decisions for their patients." The hemocue WBC Analyzer provides a count of a patient's white...

Tight Glycemic Control in the ICU

...glucose monitoring systems for the ICU include the hemocue Glucose 201 DM System, LifeScan SureStepFlexx Prof...s connectivity for Roche and LifeScan. The hemocue Glucose 201 DM System provides the glucose analyze.... Quality control (QC) must be performed with the hemocue control cuvette and commercially available glucose...

Hemoglobin Testing at the Point of Care

...ices, recent products from several manufacturers offer prompt assessment of hemoglobin values. HemoCue, Inc., Lake Forest, Calif., says that its hemocue Hemoglobin Test Systems provide quick, simple and reliable quantitative hemoglobin results with the same performance as a large hematology analyzer. T...

HemoCue in Biological Technology

HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker

...corporated (NYSE: DGX ), today announced that its hemocue Albumin 201 System is the first quantitative point...cate of Waiver in the U.S. will be able to use the hemocue Albumin 201 System to screen patients for microalb... cardiovascular disease onset and progression. The hemocue Albumin 201 System, which produces results within ...

Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening

... test can be obtained from Quest Diagnostics. Both hemocue and Enterix are companies owned by Quest Diagnosti... http://www.insuretest.com . About HemoCue The hemocue family of companies, acquired by Quest Diagnostics... near patient, or point-of-care, testing. In 1982, hemocue AB, based in Angelholm, Sweden, introduced the fir...